Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Clinical trial NCT01148524 · COMPLETED

Trial details

NCT number: NCT01148524
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Meningococcal Disease Meningococcal Meningitis

Start date: 2010-08-01
Primary completion: 2012-01-01
Enrollment: 817

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.